Hematology Research Unit Helsinki

Hematology Research Unit Helsinki (HRUH) is a translational research group, which aims to understand the pathobiology of malignant blood diseases (such as leukemia) and related autoimmune disorders and find novel therapy targets and modes of action. We combine basic cancer research with clinical drug studies and our long-term goal is to develop curative treatment strategies for patients.
Read more

Digital health to support precision cancer medicine in iCAN – a new Academy of Finland flagship | University of He… twitter.com/i/web/status/1…

Greetings from Geneva Switzerland at #ESMOImmuno18 congress! Thank you @myESMO for the interesting congress and for… twitter.com/i/web/status/1…

#ASH18 behind, very proud of great presentations by @hruh_research, well-deserved dinner together with @HeckmanLab https://t.co/L7oB3hj4uo

#ASH18 Paper No: 4257 RUNX1 Mutations Identify an Entity of BP-CML Patients with Distinct Phenotype by Shady Awad https://t.co/7mofBb10jf

Contact Information

Hematology Research Unit Helsinki, Biomedicum 1 • Haartmaninkatu 8 • P.O. Box 700, 00029 HUCH Finland • +358-9-471-71898 (tel) • +358-9-471-71955 (lab) • +358-9-471-71897 (fax) • E-mail: firstname.lastname@helsinki.fi